Short-term high-dose intravenous methylprednisolone therapy

Short-term, high-dose intravenous methylprednisolone therapy (IVMP), which is called steroid pulse therapy, is widely used as the standard treatment for acute exacerbations of multiple sclerosis (MS), and has been shown to improve neurological symptoms. IVMP is also applied in the acute phase of neu...

Full description

Saved in:
Bibliographic Details
Published inNihon rinshō Vol. 72; no. 11; p. 1995
Main Author Ohashi, Takashi
Format Journal Article
LanguageJapanese
Published Japan 01.11.2014
Subjects
Humans
Injections, Intravenous
Methylprednisolone - administration & dosage
Methylprednisolone - adverse effects
Multiple Sclerosis - drug therapy
Neuroprotective Agents - administration & dosage
Neuroprotective Agents - adverse effects
Time Factors
Online AccessGet more information

Cover

More Information
Summary:Short-term, high-dose intravenous methylprednisolone therapy (IVMP), which is called steroid pulse therapy, is widely used as the standard treatment for acute exacerbations of multiple sclerosis (MS), and has been shown to improve neurological symptoms. IVMP is also applied in the acute phase of neuromyelitis optica (NMO), with considerable benefit, although some patients are refractory to IVMP, and the early use of plasmapheresis should be considered in these patients. IVMP acts by inhibiting the cascade of inflammation through several different mechanisms, including reducing the inflammatory cytokines and suppressing the T cell activation. IVMP is well tolerated and relatively safe, but attention should be paid to the development of adverse events, such as psychosis, hyperglycemia and osteonecrosis.
ISSN:0047-1852